1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Oxygenta Pharmaceutical Ltd
Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
36.95% Fall from 52W High
86.6
TTM PE Ratio
High in industry
10300.8
Price to Book Ratio
Negative Price to Book
-11.4
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is much higher than 1
102.9
Oxygenta Pharmaceutical Ltd Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
77.00
10Day EMA
82.00
12Day EMA
83.40
20Day EMA
85.60
26Day EMA
85.00
50Day EMA
77.80
100Day EMA
64.70
200Day EMA
52.50
5Day SMA
77.70
10Day SMA
83.30
20Day SMA
92.10
30Day SMA
91.40
50Day SMA
78.00
100Day SMA
56.40
150Day SMA
49.70
200Day SMA
45.70
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 79193 Rs | 79193 Rs |
Week Rs | 79993 Rs | 79993 Rs |
Month Rs | 21262 Rs | 21262 Rs |
Resistance & Support
71.79
Pivot
Resistance
First Resistance
73.06
Second Resistance
75.28
Third Resistance
76.55
Support
First Support
69.57
Second support
68.30
Third Support
66.08
Relative Strength Index
26.62
Money Flow Index
0.00
MACD
-1.66
MACD Signal
2.29
Average True Range
2.85
Average Directional Index
41.86
Rate of Change (21)
-26.58
Rate of Change (125)
94.11
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
Lactose (India) Ltd. | - | - | - | |
Pharmaids Pharmaceuticals Ltd. | - | - | - | |
Shukra Pharmaceuticals Ltd. | - | - | - | |
Oxygenta Pharmaceutical Ltd. | - | - | - | |
Kimia Biosciences Ltd. | - | - | - | |
Denis Chem Lab Ltd. | - | - | - | |
Vaishali Pharma Ltd. | - | - | - |
Oxygenta Pharmaceutical Ltd Company background
Founded in: 1990
Managing director: Sai Sudhakar Vankineni
Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals. Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 202122.The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs. The Company is doing contract manufacturing work for APL and also having its own production. The Company is engaged in manufacture of bulk drugs. It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and antiinflammatory drugs. The Company has plant located at Medak in Andhra Pradesh. The Company has been doing contract manufacturing work with APL for manufacturing of Cirprofloxacin HCL from QAcid and has been manufacturing Pantaprozole Sodium and Gabapentine for own production. To minimize the working capital requirement and to have consistent income, it is necessary to continue contract manufacturing work till the Company gets working capital limits from any Bank. This contract manufacturing helps it to meet major operational expenses of the Company. Since the Company started commercial production in July, 2015 after fire accident, it is in the process of stabilizing the manufacturing and marketing.
Oxygenta Pharmaceutical Ltd FAQs
What is the Mutual Fund shareholding in Oxygenta Pharmaceutical Ltd?
The Mutual Fund Shareholding was 0.03% at the end of .
How can I buy Oxygenta Pharmaceutical Ltd shares?
You can easily buy Oxygenta Pharmaceutical Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Open Demat Account
